Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03564106 |
Recruitment Status :
Completed
First Posted : June 20, 2018
Last Update Posted : January 20, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain Management | Drug: intraarticular radiofrequency + intraarticular methylprednisolone Drug: intraarticular methylprednisolone | Phase 2 Phase 3 |
The pain starts when the Sacroiliac joint gets inflamed. There are several reasons it could happen. It could be hurt when playing sports or if fall down.
Sometimes start hurting when the ligaments that hold the SI joint together are damaged, which may make the joint move abnormally. The pain associated with sacroiliitis most commonly occurs in the buttocks and lower back. It can also affect the legs, groin and even the feet.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Comparison Between Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis |
Actual Study Start Date : | March 1, 2019 |
Actual Primary Completion Date : | January 1, 2021 |
Actual Study Completion Date : | January 15, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: group A
receive intraarticular radiofrequency + methylprednisolone (30 mg)
|
Drug: intraarticular radiofrequency + intraarticular methylprednisolone
intraarticular radiofrequency + intraarticular methylprednisolone (30 mg) |
Experimental: group C
receive intraarticular methylprednisolone (30 mg)
|
Drug: intraarticular methylprednisolone
intraarticular methylprednisolone (30 mg) |
- pain intensity [ Time Frame: up to 6 months ]Numeric Rating Scale (NRS)
- Patient Impression [ Time Frame: up to 6 months ]Patient Global Impression of Change Scale (PGIC)
- Pain Disability [ Time Frame: up to 6 months ]Pain Disability Index ( PDI)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All patients must have chronic pain more than 6 months and have failed medical treatment.
Exclusion Criteria:
- Infection at the site of injection
- Opioids addiction
- Coagulopathy or another bleeding diathesis
- Those who refuse to participate in the study
- Ankylosing Spondylitis patients

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03564106
Egypt | |
Assiut governorate | |
Assiut, Egypt |
Responsible Party: | Ghada Mohammed AboelFadl, Principal Investigator, Assiut University |
ClinicalTrials.gov Identifier: | NCT03564106 |
Other Study ID Numbers: |
17200203 |
First Posted: | June 20, 2018 Key Record Dates |
Last Update Posted: | January 20, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
chronic sacroilitis,radiofrequancy,intraarticular steroids injection |
Sacroiliitis Arthritis Joint Diseases Musculoskeletal Diseases Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Anti-Inflammatory Agents |
Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Gastrointestinal Agents Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Neuroprotective Agents Protective Agents Antineoplastic Agents, Hormonal Antineoplastic Agents |